List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 27 studies with search of: "Deferoxamine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
Condition: Thalassemia
Interventions: Drug: Deferoxamine;   Drug: Deferasirox
2 Recruiting Deferoxamine in Myeloablative Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndromes or Acute Leukemia and Iron Overload
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome
Intervention: Drug: deferoxamine mesylate
3 Recruiting Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion
Condition: Acute Ischemic Stroke
Intervention: Drug: Deferoxamine
4 Recruiting Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
Conditions: Transfusional Iron Overload in the Heart;   Transfusional Hemosiderosis
Interventions: Drug: Deferasirox;   Drug: Deferoxamine
5 Completed Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
Condition: Anemia, Sickle Cell
Interventions: Drug: ICL670;   Drug: deferoxamine
6 Active, not recruiting Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
Condition: Intracerebral Hemorrhage
Intervention: Drug: Deferoxamine Mesylate
7 Completed Safety & Efficacy of ICL670 Vs. Deferoxamine in Beta-Thalassemia Patients With Iron Overload Due to Blood Transfusions
Condition: Beta-Thalassemia
Interventions: Drug: ICL670;   Drug: deferoxamine
8 Completed Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
Conditions: Iron Overload;   Cardiomyopathy
Interventions: Drug: Deferoxamine and Deferiprone;   Drug: Deferoxamine
9 Recruiting N-Acetylcysteine Plus Deferoxamine for Patients With Hypotension
Conditions: Hypotension;   Acute Renal Failure
Intervention: Drug: N-acetylcysteine and deferoxamine
10 Completed Efficacy Study in Removing Excess Iron From the Heart
Conditions: Thalassemia Major;   Hemosiderosis
Interventions: Drug: Ferriprox (deferiprone);   Drug: Desferal (deferoxamine)
11 Active, not recruiting Pilot Study for Patients With Poor Response to Deferasirox
Conditions: Transfusion-Dependent Hemachromatosis;   Thalassemia Major;   Sickle Cell Disease
Interventions: Drug: Deferoxamine;   Drug: Deferasirox;   Radiation: HIDA
12 Recruiting Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-Dependent Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
13 Active, not recruiting Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
14 Completed Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
Conditions: Anemia (Iron-Loading);   Beta-Thalassemia;   Hematologic Diseases;   Hemoglobinopathies;   Thalassemia;   Iron Overload;   Hemochromatosis
Intervention: Drug: deferoxamine
15 Completed Study of Deferasirox in Iron Overload From Beta-Thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Conditions: Beta-Thalassemia;   Myelodysplastic Syndromes;   Fanconi Syndrome;   Anemia, Diamond-Blackfan;   Anemia, Aplastic
Intervention: Drug: Deferasirox
16 Active, not recruiting Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
Condition: Beta-Thalassemia
Intervention: Drug: deferiprone
17 Completed Deferoxamine for the Treatment of Hemochromatosis
Conditions: Diabetes Mellitus;   Heart Disease;   Hemochromatosis;   Thalassemia
Intervention:
18 Terminated Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Conditions: Cardiovascular Diseases;   Heart Diseases;   Beta-Thalassemia
Interventions: Drug: Deferoxamine;   Drug: Deferiprone (L1)
19 Completed Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
Conditions: Anemia, Cooley's;   Beta-Thalassemia;   Hematologic Diseases;   Thalassemia;   Osteoporosis;   Iron Overload;   Hypertension, Pulmonary
Interventions: Drug: Deferoxamine;   Drug: Deferiprone;   Drug: Arginine;   Drug: Sildenafil;   Drug: Decitabine
20 Completed Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
Conditions: Sickle Cell Disease;   Iron Overload;   Hemolytic Anemia
Intervention: Drug: Deferasirox

Previous Page Studies Shown (1-20) Next Page (21-27)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services